Navigation Links
myMatrixx Launches myRisk Predictor™ a Patent-Pending Risk Assessment Tool
Date:11/29/2011

TAMPA, Fla., Nov. 29, 2011 /PRNewswire/ -- myMatrixx®, a full-service pharmacy and ancillary medical benefits management company, announced today the release of myRisk Predictor™ a patent-pending revolutionary risk assessment tool designed to identify injured workers who are at high risk for potential abuse and misuse of prescription medications. myRisk Predictor combines predictive modeling with historical data and unique algorithms developed by the myMatrixx clinical team to develop a customized risk score for injured workers. This real-time tool alerts insurance carriers, third party administrators and self-insured entities when claimants within their populations may be in need of intervention.

(Logo: http://photos.prnewswire.com/prnh/20111005/FL81065LOGO)

"Claims adjusters are typically managing so many cases that there is little time to analyze risk associated with the medications prescribed to injured workers," stated Phil Walls, R. Ph., Chief Clinical & Compliance Officer with myMatrixx. "Additionally with alarming increases in the rates of drug costs, fraud and abuse, our clients are seeking intervention before a case may spiral out of control. This tool enhances our current processes," added Walls.

Since the perception of risk varies between populations, myRisk Predictor allows clients to uniquely assign different weights based on their specific needs. Once individuals are identified using myRisk Predictor, myMatrixx's clinical team can provide a complete drug regimen review, peer-to-peer intervention with the treating physician and assist with developing an alternative treatment plan. By identifying and treating individuals at risk earlier in the claims process, myMatrixx aims to lower the costs of care and improve outcomes for injured workers, contributing to the companies "Get Ahead of the Claim" program.

For more information on myRisk Predictor, please contact Lori Taylor, Director of Marketing and Communications, at (813) 321-1317.

About myMatrixx

myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the workers' compensation market. By combining advanced technology, clinical expertise and comprehensive reporting, myMatrixx simplifies the management of claims. Our results driven solutions deliver reduced costs for our clients and improve outcomes for their injured workers. For more information, visit www.mymatrixx.com.

Contact:

Lori Taylor, Director of Marketing and Communications

 

(877) 804-4900, ext 136 or ltaylor@mymatrixx.com


'/>"/>
SOURCE myMatrixx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. myMatrixxs Phil Walls, R.Ph. Receives National and Regional Recognition
2. ForteBio Launches Dip and Read™ Anti-GST Biosensor
3. Henry Schein Dental Launches Total Health™ Beyond the Mouth
4. U-Systems Launches somo-v Platinum Automated Breast Ultrasound System at RSNA
5. Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries
6. MedVantx Launches Patient Profile™, A Proprietary Closed-Loop Pharmaceutical Adherence Management Program for Medical Home, Accountable Care and Population Health Management
7. MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries
8. Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization
9. Prime Therapeutics Launches Retail Medication Therapy Management Program
10. Codman Launches CERTAS™ Programmable Valve for Hydrocephalus
11. HeartSine® Technologies Launches New Global Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
(Date:12/8/2016)... Mederi Therapeutics Inc . hat die behördliche Zulassung durch ... gastroösophageale Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during ... Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... California Senate Bill (SB) 863, signed into law in ... 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , ... the study, medical payments per claim in California decreased 4 percent in 2013 and ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... and financial planning services from offices headquartered in Hamilton County, is embarking on ... LuvFurMutts. , LuvFurMutts specializes in finding new homes for orphaned or neglected senior ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... ... 2016 , ... Kenall Manufacturing, a leader in sealed healthcare lighting for more ... a multi-function, sealed, LED luminaire that meets the needs of everyone in the patient ... , A 2’ x 4’ model features four modes: reading, ambient, standard ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... S.L. (“Presence”) for a purchase price of approximately $17.4 million (net of ... annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence is ...
Breaking Medicine News(10 mins):